戻る Agenda
[V1-S3] Global Contribution for Clinical Development from Japan
Session Chair(s)
Naomi Nagai, PHD
Senior Specialist for Pharmacokinetics
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Masayo Oishi, PHD
Clinical Pharmacologist, Clinical Pharmacology, Clinical Research
Pfizer Japan Inc., Japan
Speaker(s)
Meaningful Asian Phase I for GlobalDrug Development
Koji Chiba, PHD
Yokohama College of Pharmacy, Japan
Professor, Laboratory of Clinical Pharmacology
Advanced PET Molecular Imaging Technology for the Drug Development from Pharmacokinetics and DDS to Super-early Diagnosis
Tomotaka Shingaki
RIKEN Center for Life Science Technologies, Japan
Research Scientist, Molecular Dynamics Imaging Unit
Public-private partnership in Japan for global clinical development-Present status and operational challenges
Yuji Sato, MD, PHD
Sanofi K.K., Japan
Head of Japan R&D, Research and Development